REPORTS

Let’s Pullulate and Expand Your Business

Global Alpha- Antitrypsin Deficiency Treatment Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jan 14, 2020  |  163 PAGES  |  REPORT CODE: CMM261443
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Alpha- Antitrypsin Deficiency Treatment is expected to grow from USD XX.0 million in 2018 to XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period. The research provides insights for the global Alpha- Antitrypsin Deficiency Treatment market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Alpha- Antitrypsin Deficiency Treatment industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Alpha- Antitrypsin Deficiency Treatment Market Segmentations:

By Players:

  • Arrowhead Pharmaceuticals, Inc.

  • International Stem Cell Corporation

  • Intellia Therapeutics, Inc.

  • Ionis Pharmaceuticals, Inc.

  • ProMetic Life Sciences Inc.

  • Grifols, S.A.

  • Sangamo BioSciences, Inc.

  • Digna Biotech, S.L.

  • Inhibrx

  • Applied Genetic Technologies Corporation

  • Adverum Biotechnologies, Inc.

  • Alnylam Pharmaceuticals, Inc.

  • Carolus Therapeutics, Inc.

  • Cevec Pharmaceuticals GmbH

  • Dicerna Pharmaceuticals, Inc.

  • Editas Medicine, Inc.

  • Kamada Ltd.

  • Polyphor Ltd.

  • rEVO Biologics, Inc.

By Types:

  • CT-2009

  • POL-6014

  • ARO-AAT

  • ALNAAT-02

  • Others

By End-User:

  • Clinic

  • Hospital

  • Others

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Alpha- Antitrypsin Deficiency Treatment Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Alpha- Antitrypsin Deficiency Treatment Market Share by Types

    • 1.3.2 Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of CT-2009 from 2014 to 2026

    • 1.3.3 Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of POL-6014 from 2014 to 2026

    • 1.3.4 Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of ARO-AAT from 2014 to 2026

    • 1.3.5 Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of ALNAAT-02 from 2014 to 2026

    • 1.3.6 Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Others from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Alpha- Antitrypsin Deficiency Treatment Market Share by End-Users

    • 1.4.2 Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Clinic from 2014 to 2026

    • 1.4.3 Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.4 Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Others from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Alpha- Antitrypsin Deficiency Treatment Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Alpha- Antitrypsin Deficiency Treatment by Major Types

    • 3.4.1 Market Size and Growth Rate of CT-2009

    • 3.4.2 Market Size and Growth Rate of POL-6014

    • 3.4.3 Market Size and Growth Rate of ARO-AAT

    • 3.4.4 Market Size and Growth Rate of ALNAAT-02

    • 3.4.5 Market Size and Growth Rate of Others

4 Segmentation of Alpha- Antitrypsin Deficiency Treatment Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Alpha- Antitrypsin Deficiency Treatment by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Alpha- Antitrypsin Deficiency Treatment for Clinic

    • 4.4.2 Market Size and Growth Rate of Alpha- Antitrypsin Deficiency Treatment for Hospital

    • 4.4.3 Market Size and Growth Rate of Alpha- Antitrypsin Deficiency Treatment for Others

5 Market Analysis by Major Regions

  • 5.1 Global Alpha- Antitrypsin Deficiency Treatment Production Analysis by Major Regions

  • 5.2 Global Alpha- Antitrypsin Deficiency Treatment Consumption Analysis by Major Regions

  • 5.3 Global Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis

6 Product Commodity of Alpha- Antitrypsin Deficiency Treatment Market in Major Countries

  • 6.1 Top 5 Export Countries in Alpha- Antitrypsin Deficiency Treatment market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Alpha- Antitrypsin Deficiency Treatment market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Alpha- Antitrypsin Deficiency Treatment market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Alpha- Antitrypsin Deficiency Treatment market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Alpha- Antitrypsin Deficiency Treatment market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Alpha- Antitrypsin Deficiency Treatment market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Alpha- Antitrypsin Deficiency Treatment Landscape Analysis

  • 7.1 North America Alpha- Antitrypsin Deficiency Treatment Landscape Analysis by Major Types

  • 7.2 North America Alpha- Antitrypsin Deficiency Treatment Landscape Analysis by Major End-Users

  • 7.3 North America Alpha- Antitrypsin Deficiency Treatment Landscape Analysis by Major Countries

    • 7.3.1 United States Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 7.3.2 Canada Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 7.3.3 Mexico Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

8 Europe Alpha- Antitrypsin Deficiency Treatment Landscape Analysis

  • 8.1 Europe Alpha- Antitrypsin Deficiency Treatment Landscape Analysis by Major Types

  • 8.2 Europe Alpha- Antitrypsin Deficiency Treatment Landscape Analysis by Major End-Users

  • 8.3 Europe Alpha- Antitrypsin Deficiency Treatment Landscape Analysis by Major Countries

    • 8.3.1 Germany Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 8.3.2 UK Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 8.3.3 France Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 8.3.4 Italy Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 8.3.6 Spain Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 8.3.7 Belgium Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 8.3.8 Poland Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 8.3.9 Russia Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 8.3.10 Turkey Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

9 Asia Pacific Alpha- Antitrypsin Deficiency Treatment Landscape Analysis

  • 9.1 Asia Pacific Alpha- Antitrypsin Deficiency Treatment Landscape Analysis by Major Types

  • 9.2 Asia Pacific Alpha- Antitrypsin Deficiency Treatment Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Alpha- Antitrypsin Deficiency Treatment Landscape Analysis by Major Countries

    • 9.3.1 China Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 9.3.2 Japan Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 9.3.4 India Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 9.3.6 South Korea Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

10 Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 10.3.2 Brazil Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 10.3.3 Nigeria Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

    • 10.3.4 South Africa Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate 

    • 10.3.5 Argentina Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Arrowhead Pharmaceuticals, Inc.

    • 11.1.1 Arrowhead Pharmaceuticals, Inc. Company Profile and Development Status

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 International Stem Cell Corporation

    • 11.2.1 International Stem Cell Corporation Company Profile and Development Status

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Intellia Therapeutics, Inc.

    • 11.3.1 Intellia Therapeutics, Inc. Company Profile and Development Status

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Ionis Pharmaceuticals, Inc.

    • 11.4.1 Ionis Pharmaceuticals, Inc. Company Profile and Development Status

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 ProMetic Life Sciences Inc.

    • 11.5.1 ProMetic Life Sciences Inc. Company Profile and Development Status

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Grifols, S.A.

    • 11.6.1 Grifols, S.A. Company Profile and Development Status

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Sangamo BioSciences, Inc.

    • 11.7.1 Sangamo BioSciences, Inc. Company Profile and Development Status

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Digna Biotech, S.L.

    • 11.8.1 Digna Biotech, S.L. Company Profile and Development Status

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Inhibrx

    • 11.9.1 Inhibrx Company Profile and Development Status

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Applied Genetic Technologies Corporation

    • 11.10.1 Applied Genetic Technologies Corporation Company Profile and Development Status

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 Adverum Biotechnologies, Inc.

    • 11.11.1 Adverum Biotechnologies, Inc. Company Profile and Development Status

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Alnylam Pharmaceuticals, Inc.

    • 11.12.1 Alnylam Pharmaceuticals, Inc. Company Profile and Development Status

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 Carolus Therapeutics, Inc.

    • 11.13.1 Carolus Therapeutics, Inc. Company Profile and Development Status

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

  • 11.14 Cevec Pharmaceuticals GmbH

    • 11.14.1 Cevec Pharmaceuticals GmbH Company Profile and Development Status

    • 11.14.2 Market Performance

    • 11.14.3 Product and Service Introduction

  • 11.15 Dicerna Pharmaceuticals, Inc.

    • 11.15.1 Dicerna Pharmaceuticals, Inc. Company Profile and Development Status

    • 11.15.2 Market Performance

    • 11.15.3 Product and Service Introduction

  • 11.16 Editas Medicine, Inc.

    • 11.16.1 Editas Medicine, Inc. Company Profile and Development Status

    • 11.16.2 Market Performance

    • 11.16.3 Product and Service Introduction

  • 11.17 Kamada Ltd.

    • 11.17.1 Kamada Ltd. Company Profile and Development Status

    • 11.17.2 Market Performance

    • 11.17.3 Product and Service Introduction

  • 11.18 Polyphor Ltd.

    • 11.18.1 Polyphor Ltd. Company Profile and Development Status

    • 11.18.2 Market Performance

    • 11.18.3 Product and Service Introduction

  • 11.19 rEVO Biologics, Inc.

    • 11.19.1 rEVO Biologics, Inc. Company Profile and Development Status

    • 11.19.2 Market Performance

    • 11.19.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 88 Figures and 134 Tables)

  • Figure Product Picture

  • Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of CT-2009 from 2014 to 2026

  • Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of POL-6014 from 2014 to 2026

  • Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of ARO-AAT from 2014 to 2026

  • Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of ALNAAT-02 from 2014 to 2026

  • Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Clinic from 2014 to 2026

  • Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Hospital from 2014 to 2026

  • Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Alpha- Antitrypsin Deficiency Treatment Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Alpha- Antitrypsin Deficiency Treatment

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Alpha- Antitrypsin Deficiency Treatment by Different Types from 2014 to 2026

  • Table Consumption Share of Alpha- Antitrypsin Deficiency Treatment by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of CT-2009

  • Figure Market Size and Growth Rate of POL-6014

  • Figure Market Size and Growth Rate of ARO-AAT

  • Figure Market Size and Growth Rate of ALNAAT-02

  • Figure Market Size and Growth Rate of Others

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Alpha- Antitrypsin Deficiency Treatment by Different End-Users from 2014 to 2026

  • Table Consumption Share of Alpha- Antitrypsin Deficiency Treatment by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Clinic

  • Figure Market Size and Growth Rate of Hospital

  • Figure Market Size and Growth Rate of Others

  • Table Global Alpha- Antitrypsin Deficiency Treatment Production by Major Regions

  • Table Global Alpha- Antitrypsin Deficiency Treatment Production Share by Major Regions

  • Figure Global Alpha- Antitrypsin Deficiency Treatment Production Share by Major Regions in 2014

  • Figure Global Alpha- Antitrypsin Deficiency Treatment Production Share by Major Regions in 2018

  • Figure Global Alpha- Antitrypsin Deficiency Treatment Production Share by Major Regions in 2026

  • Table Global Alpha- Antitrypsin Deficiency Treatment Consumption by Major Regions

  • Table Global Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Regions

  • Figure Global Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Regions in 2014

  • Figure Global Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Regions in 2018

  • Figure Global Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Regions in 2026

  • Table North America Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis

  • Table Europe Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Alpha- Antitrypsin Deficiency Treatment market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Alpha- Antitrypsin Deficiency Treatment market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Alpha- Antitrypsin Deficiency Treatment market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Alpha- Antitrypsin Deficiency Treatment market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Alpha- Antitrypsin Deficiency Treatment Consumption by Types from 2014 to 2026

  • Table North America Alpha- Antitrypsin Deficiency Treatment Consumption Share by Types from 2014 to 2026

  • Figure North America Alpha- Antitrypsin Deficiency Treatment Consumption Share by Types in 2014

  • Figure North America Alpha- Antitrypsin Deficiency Treatment Consumption Share by Types in 2018

  • Figure North America Alpha- Antitrypsin Deficiency Treatment Consumption Share by Types in 2026

  • Table North America Alpha- Antitrypsin Deficiency Treatment Consumption by End-Users from 2014 to 2026

  • Table North America Alpha- Antitrypsin Deficiency Treatment Consumption Share by End-Users from 2014 to 2026

  • Figure North America Alpha- Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2014

  • Figure North America Alpha- Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2018

  • Figure North America Alpha- Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2026

  • Table North America Alpha- Antitrypsin Deficiency Treatment Consumption by Major Countries from 2014 to 2026

  • Table North America Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2014

  • Figure North America Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2018

  • Figure North America Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2026

  • Figure United States Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Alpha- Antitrypsin Deficiency Treatment Consumption by Types from 2014 to 2026

  • Table Europe Alpha- Antitrypsin Deficiency Treatment Consumption Share by Types from 2014 to 2026

  • Figure Europe Alpha- Antitrypsin Deficiency Treatment Consumption Share by Types in 2014

  • Figure Europe Alpha- Antitrypsin Deficiency Treatment Consumption Share by Types in 2018

  • Figure Europe Alpha- Antitrypsin Deficiency Treatment Consumption Share by Types in 2026

  • Table Europe Alpha- Antitrypsin Deficiency Treatment Consumption by End-Users from 2014 to 2026

  • Table Europe Alpha- Antitrypsin Deficiency Treatment Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Alpha- Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2014

  • Figure Europe Alpha- Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2018

  • Figure Europe Alpha- Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2026

  • Table Europe Alpha- Antitrypsin Deficiency Treatment Consumption by Major Countries from 2014 to 2026

  • Table Europe Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2014

  • Figure Europe Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2018

  • Figure Europe Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2026

  • Figure Germany Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure France Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Alpha- Antitrypsin Deficiency Treatment Consumption by Types from 2014 to 2026

  • Table Asia Pacific Alpha- Antitrypsin Deficiency Treatment Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Alpha- Antitrypsin Deficiency Treatment Consumption Share by Types in 2014

  • Figure Asia Pacific Alpha- Antitrypsin Deficiency Treatment Consumption Share by Types in 2018

  • Figure Asia Pacific Alpha- Antitrypsin Deficiency Treatment Consumption Share by Types in 2026

  • Table Asia Pacific Alpha- Antitrypsin Deficiency Treatment Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Alpha- Antitrypsin Deficiency Treatment Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Alpha- Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2014

  • Figure Asia Pacific Alpha- Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2018

  • Figure Asia Pacific Alpha- Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2026

  • Table Asia Pacific Alpha- Antitrypsin Deficiency Treatment Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2026

  • Figure China Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandAlpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure India Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2026

  • Figure GCC Countries Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Alpha- Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Arrowhead Pharmaceuticals, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arrowhead Pharmaceuticals, Inc.

  • Figure Sales and Growth Rate Analysis of Arrowhead Pharmaceuticals, Inc.

  • Figure Revenue and Market Share Analysis of Arrowhead Pharmaceuticals, Inc.

  • Table Product and Service Introduction of Arrowhead Pharmaceuticals, Inc.

  • Table Company Profile and Development Status of International Stem Cell Corporation

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of International Stem Cell Corporation

  • Figure Sales and Growth Rate Analysis of International Stem Cell Corporation

  • Figure Revenue and Market Share Analysis of International Stem Cell Corporation

  • Table Product and Service Introduction of International Stem Cell Corporation

  • Table Company Profile and Development Status of Intellia Therapeutics, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intellia Therapeutics, Inc.

  • Figure Sales and Growth Rate Analysis of Intellia Therapeutics, Inc.

  • Figure Revenue and Market Share Analysis of Intellia Therapeutics, Inc.

  • Table Product and Service Introduction of Intellia Therapeutics, Inc.

  • Table Company Profile and Development Status of Ionis Pharmaceuticals, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ionis Pharmaceuticals, Inc.

  • Figure Sales and Growth Rate Analysis of Ionis Pharmaceuticals, Inc.

  • Figure Revenue and Market Share Analysis of Ionis Pharmaceuticals, Inc.

  • Table Product and Service Introduction of Ionis Pharmaceuticals, Inc.

  • Table Company Profile and Development Status of ProMetic Life Sciences Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ProMetic Life Sciences Inc.

  • Figure Sales and Growth Rate Analysis of ProMetic Life Sciences Inc.

  • Figure Revenue and Market Share Analysis of ProMetic Life Sciences Inc.

  • Table Product and Service Introduction of ProMetic Life Sciences Inc.

  • Table Company Profile and Development Status of Grifols, S.A.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols, S.A.

  • Figure Sales and Growth Rate Analysis of Grifols, S.A.

  • Figure Revenue and Market Share Analysis of Grifols, S.A.

  • Table Product and Service Introduction of Grifols, S.A.

  • Table Company Profile and Development Status of Sangamo BioSciences, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sangamo BioSciences, Inc.

  • Figure Sales and Growth Rate Analysis of Sangamo BioSciences, Inc.

  • Figure Revenue and Market Share Analysis of Sangamo BioSciences, Inc.

  • Table Product and Service Introduction of Sangamo BioSciences, Inc.

  • Table Company Profile and Development Status of Digna Biotech, S.L.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Digna Biotech, S.L.

  • Figure Sales and Growth Rate Analysis of Digna Biotech, S.L.

  • Figure Revenue and Market Share Analysis of Digna Biotech, S.L.

  • Table Product and Service Introduction of Digna Biotech, S.L.

  • Table Company Profile and Development Status of Inhibrx

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Inhibrx

  • Figure Sales and Growth Rate Analysis of Inhibrx

  • Figure Revenue and Market Share Analysis of Inhibrx

  • Table Product and Service Introduction of Inhibrx

  • Table Company Profile and Development Status of Applied Genetic Technologies Corporation

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Applied Genetic Technologies Corporation

  • Figure Sales and Growth Rate Analysis of Applied Genetic Technologies Corporation

  • Figure Revenue and Market Share Analysis of Applied Genetic Technologies Corporation

  • Table Product and Service Introduction of Applied Genetic Technologies Corporation

  • Table Company Profile and Development Status of Adverum Biotechnologies, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adverum Biotechnologies, Inc.

  • Figure Sales and Growth Rate Analysis of Adverum Biotechnologies, Inc.

  • Figure Revenue and Market Share Analysis of Adverum Biotechnologies, Inc.

  • Table Product and Service Introduction of Adverum Biotechnologies, Inc.

  • Table Company Profile and Development Status of Alnylam Pharmaceuticals, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals, Inc.

  • Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals, Inc.

  • Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals, Inc.

  • Table Product and Service Introduction of Alnylam Pharmaceuticals, Inc.

  • Table Company Profile and Development Status of Carolus Therapeutics, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Carolus Therapeutics, Inc.

  • Figure Sales and Growth Rate Analysis of Carolus Therapeutics, Inc.

  • Figure Revenue and Market Share Analysis of Carolus Therapeutics, Inc.

  • Table Product and Service Introduction of Carolus Therapeutics, Inc.

  • Table Company Profile and Development Status of Cevec Pharmaceuticals GmbH

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cevec Pharmaceuticals GmbH

  • Figure Sales and Growth Rate Analysis of Cevec Pharmaceuticals GmbH

  • Figure Revenue and Market Share Analysis of Cevec Pharmaceuticals GmbH

  • Table Product and Service Introduction of Cevec Pharmaceuticals GmbH

  • Table Company Profile and Development Status of Dicerna Pharmaceuticals, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dicerna Pharmaceuticals, Inc.

  • Figure Sales and Growth Rate Analysis of Dicerna Pharmaceuticals, Inc.

  • Figure Revenue and Market Share Analysis of Dicerna Pharmaceuticals, Inc.

  • Table Product and Service Introduction of Dicerna Pharmaceuticals, Inc.

  • Table Company Profile and Development Status of Editas Medicine, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Editas Medicine, Inc.

  • Figure Sales and Growth Rate Analysis of Editas Medicine, Inc.

  • Figure Revenue and Market Share Analysis of Editas Medicine, Inc.

  • Table Product and Service Introduction of Editas Medicine, Inc.

  • Table Company Profile and Development Status of Kamada Ltd.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kamada Ltd.

  • Figure Sales and Growth Rate Analysis of Kamada Ltd.

  • Figure Revenue and Market Share Analysis of Kamada Ltd.

  • Table Product and Service Introduction of Kamada Ltd.

  • Table Company Profile and Development Status of Polyphor Ltd.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Polyphor Ltd.

  • Figure Sales and Growth Rate Analysis of Polyphor Ltd.

  • Figure Revenue and Market Share Analysis of Polyphor Ltd.

  • Table Product and Service Introduction of Polyphor Ltd.

  • Table Company Profile and Development Status of rEVO Biologics, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of rEVO Biologics, Inc.

  • Figure Sales and Growth Rate Analysis of rEVO Biologics, Inc.

  • Figure Revenue and Market Share Analysis of rEVO Biologics, Inc.

  • Table Product and Service Introduction of rEVO Biologics, Inc.


Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top